Merit Medical Systems Inc.

MMSI | NASDAQ

Price Alert Chart Builder DCF Calculator

$87.26

+$1.77 (+2.07%)

Sep 22, 2026, 4:00 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+2.07%

(1D)

Rating

Updated: Sep 18, 2026

58.1

Fundamentals Strong

Market Sentiment Bullish

Moat Narrow

Full Analysis

Key Statistics

Market Data

Market Cap $5.21B

1D Range

85.51 87.79

52W Range

59.74 94.75

Valuation (TTM)

PE 35.33

PB 3.04

EV/EBITDA 21.45

Valuation (NTM)

Forward PE 17.83

Forward PEG 4.86

Price Target $101.88

Cash Flow

FCF Yield 4.7%

SBC Adj. FCF Yield 3.8%

SBC Impact -19.0%

Margins

Gross Margin 49.5%

Operating Margin 12.7%

FCF Margin 15.1%

Growth (CAGR)

Revenue 3Y | 5Y 9.6% | 8.9%

Dil EPS 3Y | 5Y 15.8% | 37.1%

FCF 3Y | 5Y 69.7% | 12.5%

Returns

ROA 5.1%

ROE 9.1%

ROIC 5.8%

Financial Health

Net Debt

$418.51M

Current Ratio 4.20

Interest Coverage 6.34

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Merit Medical Systems, Inc. (MMSI) is engaged in the design, development, manufacturing, and worldwide commercialization of disposable medical products. These devices are crucial for a broad spectrum ...

Sector Healthcare

Industry Medical - Instruments & Supplies

Employees 7,500

IPO Date May 13, 1990

Website www.merit.com

Fiscal Year January - December

Full Company Profile

Latest News

20 days ago · globenewswire.com

Merit Medical to Participate in Upcoming Investors Conferences in September

SOUTH JORDAN, Utah, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that management is scheduled to participate in the following upcoming investor conferences:

22 days ago · zacks.com

Here's Why You Should Add Merit Medical Stock to Your Portfolio Now

MMSI's broad portfolio, R&D investments and WRAPSODY opportunity support growth, while tariffs, China pressure and competition remain risks.

1 month ago · zacks.com

Should You Buy MMSI as Growth Improves but Valuation Stays Elevated?

Merit Medical's growth case is strengthening as launches, acquisitions and therapeutic products broaden its mix, but its premium valuation raises the execution bar.

1 month ago · zacks.com

Can MMSI Sustain Its 22.2% Gain in the Past Month as Growth Improves?

Merit Medical's 22.2% monthly rally gains support from stronger Q2 growth and a raised 2026 outlook, but valuation and tariff risks remain.

1 month ago · zacks.com

Here's Why Merit Medical (MMSI) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

1 month ago · defenseworld.net

Merit Medical Eyes Next Growth Plan as Margins, Portfolio Review Take Center Stage

Merit Medical Systems (NASDAQ: MMSI) is focused on completing the objectives of its current long-range plan while developing its next strategic framework, Chief Financial Officer and Treasurer Raul Parra said during a Canaccord investor event. Parra said the company remains "hyper-focused" on executing its current CGI plan and does not want to "drop the football on

1 month ago · seekingalpha.com

Merit Medical Systems, Inc. (MMSI) Presents at Bank of America SMID Cap Virtual Conference Transcript

2 months ago · globenewswire.com

Merit Medical to Participate in Upcoming Investors Conferences in August

SOUTH JORDAN, Utah, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that management will participate in the upcoming investor conferences: